ECSP003747A - Metodo y composiciones para el tratamiento de las enfermedades pulmonares - Google Patents

Metodo y composiciones para el tratamiento de las enfermedades pulmonares

Info

Publication number
ECSP003747A
ECSP003747A EC2000003747A ECSP003747A ECSP003747A EC SP003747 A ECSP003747 A EC SP003747A EC 2000003747 A EC2000003747 A EC 2000003747A EC SP003747 A ECSP003747 A EC SP003747A EC SP003747 A ECSP003747 A EC SP003747A
Authority
EC
Ecuador
Prior art keywords
treatment
compositions
pulmonary diseases
diseases
phosphodiesterase
Prior art date
Application number
EC2000003747A
Other languages
English (en)
Spanish (es)
Inventor
Theodore Torphy
Richard Nieman
Peter GOODFELLOW
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ECSP003747A publication Critical patent/ECSP003747A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EC2000003747A 1999-11-02 2000-10-31 Metodo y composiciones para el tratamiento de las enfermedades pulmonares ECSP003747A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02

Publications (1)

Publication Number Publication Date
ECSP003747A true ECSP003747A (es) 2002-05-23

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2000003747A ECSP003747A (es) 1999-11-02 2000-10-31 Metodo y composiciones para el tratamiento de las enfermedades pulmonares

Country Status (29)

Country Link
EP (1) EP1225866A4 (tr)
JP (1) JP2003513028A (tr)
KR (1) KR20020057988A (tr)
CN (1) CN1387404A (tr)
AP (1) AP2002002496A0 (tr)
AR (1) AR029189A1 (tr)
AU (1) AU1357501A (tr)
BG (1) BG106748A (tr)
BR (1) BR0015270A (tr)
CA (1) CA2388333A1 (tr)
CO (1) CO5261512A1 (tr)
CZ (1) CZ20021512A3 (tr)
DZ (1) DZ3225A1 (tr)
EA (1) EA200200518A1 (tr)
EC (1) ECSP003747A (tr)
HK (1) HK1049107A1 (tr)
HU (1) HUP0203152A3 (tr)
IL (1) IL149367A0 (tr)
MA (1) MA26841A1 (tr)
MX (1) MXPA02004350A (tr)
NO (1) NO20022057L (tr)
OA (1) OA12076A (tr)
PE (1) PE20011005A1 (tr)
PL (1) PL355261A1 (tr)
SK (1) SK7592002A3 (tr)
TR (1) TR200201211T2 (tr)
TW (1) TWI242431B (tr)
WO (1) WO2001032127A2 (tr)
ZA (1) ZA200203435B (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL160271A0 (en) 2001-09-19 2004-07-25 Altana Pharma Ag Pharmaceutical compositions containing pde4-inhibitors and nsaid
MXPA04003668A (es) * 2001-10-31 2004-07-22 Merck Patent Gmbh Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
CA2520577A1 (en) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co., Ltd. Pharmaceutical composition
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
JPWO2006041121A1 (ja) * 2004-10-13 2008-05-15 協和醗酵工業株式会社 慢性皮膚疾患の治療および／または予防剤
AU2006305620A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
CN102665807A (zh) 2010-01-05 2012-09-12 微剂量治疗技术公司 吸入设备和方法
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT710109E (pt) * 1993-06-18 2005-01-31 Smithkline Beecham Corp Metodo para identificar um inibidor de pde iv
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
PE20011005A1 (es) 2001-09-28
SK7592002A3 (en) 2002-11-06
MA26841A1 (fr) 2004-12-20
TWI242431B (en) 2005-11-01
ZA200203435B (en) 2003-06-25
CA2388333A1 (en) 2001-05-10
IL149367A0 (en) 2002-11-10
CN1387404A (zh) 2002-12-25
NO20022057L (no) 2002-06-27
HUP0203152A3 (en) 2004-06-28
AU1357501A (en) 2001-05-14
CZ20021512A3 (cs) 2003-04-16
HUP0203152A2 (hu) 2003-01-28
KR20020057988A (ko) 2002-07-12
JP2003513028A (ja) 2003-04-08
WO2001032127A3 (en) 2001-12-06
CO5261512A1 (es) 2003-03-31
NO20022057D0 (no) 2002-04-30
DZ3225A1 (fr) 2001-05-10
OA12076A (en) 2006-05-04
BR0015270A (pt) 2002-06-18
EP1225866A4 (en) 2004-04-21
BG106748A (en) 2003-02-28
EA200200518A1 (ru) 2002-10-31
AP2002002496A0 (en) 2002-06-30
PL355261A1 (en) 2004-04-05
AR029189A1 (es) 2003-06-18
EP1225866A2 (en) 2002-07-31
TR200201211T2 (tr) 2002-08-21
MXPA02004350A (es) 2002-11-07
HK1049107A1 (zh) 2003-05-02
WO2001032127A2 (en) 2001-05-10

Similar Documents

Publication Publication Date Title
AR022072A1 (es) Terapias y composiciones para tratar enfermedades pulmonares
CR7043A (es) Derivados de eteres utiles como ganetes inhibidores de las isozimas pde4
WO2005073224A3 (en) Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer
BR0008922A (pt) Compostos úteis como agentes antiinflamatórios
BR0107934A (pt) Carboxamidas de pirimidina úteis como inibidores de isozimas pde4
MXPA04000793A (es) Novedoso metodo terapeutico.
ES2139754T3 (es) 3-fenil-2-isoxazolinas como agentes antiinflamatorios.
WO2007005668A3 (en) Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer
DOP2006000210A (es) Compuestos de pirimidina amida como inhibidores de pgds
BRPI0511383A (pt) composto, composição farmacêutica, uso de composto, método para o tratamento de um sujeito que sofre com uma condição patológica ou doença susceptìvel de melhora por inibição de fosfodiesterase 4 e produto combinado
BR0009446A (pt) Composto, processo para preparar o mesmo, composição uso de um composto, e, métodos para o tratamento ou a prevenção de uma doença em um mamìfero, para o tratamento ou a prevenção de asma em um mamìfero e para o tratamento ou a prevenção de doença pulmonar obstrutiva crÈnica em um mamìfero
WO2008057252A3 (en) Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and use therewith
DK1819227T3 (da) Farmaceutisk formulering af decitabin
WO2006063111A3 (en) Pharmaceutical formulations cytidine analogs and derivatives
WO2005061467A3 (en) Piperazine derivatives as bradykinin antagonists
ITMI20031311A1 (it) Formulazioni per il trattamento di disturbi artrosici.
BR0008382A (pt) Formulação de liberação controlada para tratamento de copd
BR0015270A (pt) Método e composições para tratamento de doenças pulmonares
MX2009008548A (es) Formulaciones de olopatadina para administracion nasal topica.
UY26423A1 (es) Metodo y composiciones para el tratamiento de las enfermedades pulmonares
WO2006041888A3 (en) Substituted aryl or heteroarylsulfonylbutanamides for use as anti-inflammatory agents
BRPI0416202A (pt) formulações inibidoras de fosfodiesterase v
WO2005089068A3 (en) Pharmaceutical compositions comprising anti-inflammatory quinazolinecarboxamide derivatives
BRPI0516383A (pt) derivados cìclicos de sulfonil amino e o uso dos mesmos
WO2000054770A8 (en) Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis